Engineers Gate Manager LP Has Upped Intra Cellular Therapies (ITCI) Stake By $775,047; Brandywine Global Investment Management Increased Its Phillips 66 (PSX) Holding

June 19, 2018 - By Hazel Jackson

Phillips 66 (NYSE:PSX) Logo

Engineers Gate Manager Lp increased Intra Cellular Therapies Inc (ITCI) stake by 125.53% reported in 2018Q1 SEC filing. Engineers Gate Manager Lp acquired 36,907 shares as Intra Cellular Therapies Inc (ITCI)’s stock rose 11.05%. The Engineers Gate Manager Lp holds 66,308 shares with $1.40M value, up from 29,401 last quarter. Intra Cellular Therapies Inc now has $1.10 billion valuation. The stock decreased 1.03% or $0.21 during the last trading session, reaching $20.18. About 222,928 shares traded. Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) has risen 115.54% since June 19, 2017 and is uptrending. It has outperformed by 102.97% the S&P500. Some Historical ITCI News: ; 11/05/2018 – Lumateperone (Intra-Cellular Therapies) Drug Overview: A Serotonin 5-HT2A Receptor Antagonist, a Modulator of the Dopaminergic and Glutamatergic Systems, and a Serotonin Reuptake Inhibitor – ResearchAndMarkets; 16/04/2018 – Intra-Cellular Closes Above 50-Day Moving Average: Technicals; 13/03/2018 – ITCI REPORTS POSITIVE PRE-NDA MEETING WITH FDA FOR LUMATEPERONE; 29/05/2018 – Intra-Cellular Therapies Announces Presentations on Lumateperone at the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting; 13/03/2018 – INTRA-CELLULAR THERAPIES INC – FDA AGREED ON PROPOSED CONTENT AND TIMING OF A ROLLING NDA SUBMISSION; 31/05/2018 – Intra-Cellular Therapies Presents Data on Symptom Improvement by Lumateperone on Negative Symptoms, Depression, and Social Function in Patients with Schizophrenia at the American Society of Clinical Psychopharmacology (ASCP) Annual…; 29/05/2018 – Intra-Cellular Therapies Announces Presentations on Lumateperone at the American Society of Clinical Psychopharmacology (ASCP); 26/04/2018 – Intra-Cellular Therapies Presents Data on lTl-214 at the 2018 American Academy of Neurology Annual Meeting; 13/03/2018 – INTRA-CELLULAR THERAPIES – HAD POSITIVE PRE-NDA MEETING WITH FDA REGARDING LUMATEPERONE FOR TREATMENT OF SCHIZOPHRENIA; 13/03/2018 – INTRA-CELLULAR THERAPIES INC – PLANS TO COMPLETE ITS NDA SUBMISSION BY MID-2018

Brandywine Global Investment Management Llc increased Phillips 66 (PSX) stake by 10.41% reported in 2018Q1 SEC filing. Brandywine Global Investment Management Llc acquired 49,220 shares as Phillips 66 (PSX)’s stock rose 24.95%. The Brandywine Global Investment Management Llc holds 521,928 shares with $50.06M value, up from 472,708 last quarter. Phillips 66 now has $53.47 billion valuation. The stock decreased 0.14% or $0.16 during the last trading session, reaching $114.78. About 952,989 shares traded. Phillips 66 (NYSE:PSX) has risen 49.32% since June 19, 2017 and is uptrending. It has outperformed by 36.75% the S&P500. Some Historical PSX News: ; 27/04/2018 – Phillips 66 1Q Transportation Adjusted Net Income $136 Million; 09/05/2018 – PHILLIPS 66 REPORTS BOOST IN QTRLY DIV; 16/04/2018 – PHILLIPS 66 JV BORGER TEXAS REFINERY RESTARTING GASOLINE UNITS; 09/05/2018 – PHILLIPS 66 BOOSTS QTRLY DIV 80C/SHR FROM 70C, EST, 79C; 06/04/2018 – PHILLIPS 66 JV BORGER TEXAS REFINERY TO COMPLETE UNIT RESTARTS NEXT WEEK; 08/03/2018 – PHILLIPS 66 JV BORGER TEXAS REFINERY SHUTS GASOLINE UNIT AS PLANTWIDE OVERHAUL CONTINUES; 27/04/2018 – Phillips 66 1Q EPS $1.07; 03/04/2018 – Phllips 66 Alliance refinery restarting hydrotreaters this week; 21/04/2018 – DJ Phillips 66, Inst Holders, 1Q 2018 (PSX); 09/05/2018 – MOODY’S RATES DCP MIDSTREAM, LP’S PROPOSED PREFERRED UNITS B1

More important recent Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) news were published by: Nasdaq.com which released: “New Research: Key Drivers of Growth for CSW Industrials, Cavco Industries, Intra-Cellular Therapies, Atrion, QAD, and …” on May 24, 2018, also Nasdaq.com published article titled: “Intra-Cellular Therapies Presents Data on Symptom Improvement by Lumateperone on Negative Symptoms …”, Globenewswire.com published: “Intra-Cellular Therapies Announces Presentations on Lumateperone at the American Society of Clinical …” on May 29, 2018. More interesting news about Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) was released by: Streetinsider.com and their article: “Intra-Cellular Therapies (ITCI) Highlights Data on Symptom Improvement by Lumateperone on Negative Symptoms …” with publication date: May 31, 2018.

Since January 3, 2018, it had 0 insider buys, and 9 selling transactions for $1.97 million activity. $17,394 worth of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) was sold by Davis Robert E on Wednesday, January 3. Mates Sharon had sold 11,257 shares worth $192,270. 772 shares valued at $13,479 were sold by Vanover Kimberly E. on Monday, January 8. Halstead Michael had sold 4,220 shares worth $69,179 on Wednesday, January 3. 49,700 shares were sold by Hineline Lawrence J., worth $995,165 on Thursday, February 15.

Among 13 analysts covering Intra-Cellular Therapies (NASDAQ:ITCI), 12 have Buy rating, 0 Sell and 1 Hold. Therefore 92% are positive. Intra-Cellular Therapies had 48 analyst reports since August 6, 2015 according to SRatingsIntel. As per Wednesday, August 23, the company rating was maintained by Piper Jaffray. SunTrust downgraded Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) on Thursday, September 29 to “Neutral” rating. Cantor Fitzgerald maintained the shares of ITCI in report on Wednesday, November 8 with “Buy” rating. Cantor Fitzgerald maintained Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) on Wednesday, August 23 with “Buy” rating. The company was upgraded on Wednesday, August 30 by Ladenburg. As per Wednesday, August 23, the company rating was upgraded by Leerink Swann. The firm earned “Buy” rating on Monday, April 2 by Cantor Fitzgerald. Piper Jaffray initiated the shares of ITCI in report on Thursday, June 2 with “Overweight” rating. The stock of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) has “Outperform” rating given on Friday, November 6 by RBC Capital Markets. The stock of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) has “Buy” rating given on Thursday, May 3 by Cantor Fitzgerald.

Investors sentiment decreased to 0.96 in Q1 2018. Its down 0.50, from 1.46 in 2017Q4. It worsened, as 17 investors sold ITCI shares while 40 reduced holdings. 21 funds opened positions while 34 raised stakes. 38.33 million shares or 2.42% more from 37.43 million shares in 2017Q4 were reported. Premier Asset Mngmt Limited Liability Co reported 19,088 shares. Boothbay Fund Mngmt Lc holds 0.03% or 11,300 shares in its portfolio. Gsa Ptnrs Limited Liability Partnership invested in 44,194 shares or 0.05% of the stock. 2,497 are owned by Employees Retirement Association Of Colorado. Great West Life Assurance Can reported 0% in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Metropolitan Life Insurance New York holds 0% or 14,016 shares in its portfolio. Perigon Wealth Mgmt Ltd Liability Corporation reported 35,955 shares or 0.28% of all its holdings. State Board Of Administration Of Florida Retirement System holds 17,062 shares or 0% of its portfolio. Us Bancorp De holds 0% of its portfolio in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) for 1,725 shares. Shanda Asset Ltd holds 35,278 shares. Hanseatic Management Svcs holds 42 shares. Keybank National Association Oh reported 0% of its portfolio in Intra-Cellular Therapies, Inc. (NASDAQ:ITCI). Tocqueville Asset Management LP stated it has 17,560 shares. Rhumbline Advisers holds 42,816 shares or 0% of its portfolio. Duquesne Family Office Limited Co invested in 0.35% or 296,986 shares.

Engineers Gate Manager Lp decreased Mks Instrument Inc (NASDAQ:MKSI) stake by 14,162 shares to 13,485 valued at $1.56 million in 2018Q1. It also reduced Rh stake by 34,639 shares and now owns 28,902 shares. United States Stl Corp New (NYSE:X) was reduced too.

Among 20 analysts covering Phillips 66 (NYSE:PSX), 10 have Buy rating, 2 Sell and 8 Hold. Therefore 50% are positive. Phillips 66 had 83 analyst reports since August 4, 2015 according to SRatingsIntel. The rating was reinitiated by Credit Suisse with “Neutral” on Wednesday, March 7. The stock of Phillips 66 (NYSE:PSX) earned “Buy” rating by Piper Jaffray on Monday, April 23. The stock has “Neutral” rating by JP Morgan on Monday, June 4. As per Wednesday, November 15, the company rating was maintained by UBS. The stock of Phillips 66 (NYSE:PSX) earned “Market Perform” rating by Wells Fargo on Friday, July 8. RBC Capital Markets maintained Phillips 66 (NYSE:PSX) on Monday, November 2 with “Sector Perform” rating. The company was initiated on Thursday, May 19 by UBS. The stock of Phillips 66 (NYSE:PSX) earned “Equal-Weight” rating by Barclays Capital on Tuesday, October 10. As per Monday, August 22, the company rating was maintained by Piper Jaffray. The firm earned “Hold” rating on Monday, September 4 by Jefferies.

Investors sentiment decreased to 0.91 in Q1 2018. Its down 0.10, from 1.01 in 2017Q4. It turned negative, as 55 investors sold PSX shares while 389 reduced holdings. 97 funds opened positions while 308 raised stakes. 314.13 million shares or 10.62% less from 351.44 million shares in 2017Q4 were reported. 52,826 are held by Amalgamated Comml Bank. Piedmont Invest Advisors Ltd Liability Co has invested 0.28% in Phillips 66 (NYSE:PSX). Tiedemann Advisors Limited Liability Company holds 0.05% of its portfolio in Phillips 66 (NYSE:PSX) for 7,713 shares. Vident Investment Advisory Ltd invested in 0.02% or 4,372 shares. Mitchell Sinkler And Starr Pa owns 4,483 shares. Moors And Cabot has invested 0.16% of its portfolio in Phillips 66 (NYSE:PSX). Azimuth Mgmt Ltd holds 0.02% of its portfolio in Phillips 66 (NYSE:PSX) for 3,279 shares. Gotham Asset Mgmt Lc has invested 0.26% in Phillips 66 (NYSE:PSX). Gamco Et Al accumulated 59,062 shares. Ironwood Finance Limited Liability Corporation holds 30 shares. 461 are held by Kings Point. Jfs Wealth Advsr Limited holds 130 shares. Moreover, Retail Bank Of Montreal Can has 0.05% invested in Phillips 66 (NYSE:PSX). Torray Ltd invested 0.14% of its portfolio in Phillips 66 (NYSE:PSX). Regentatlantic Ltd Liability Corporation stated it has 0.39% of its portfolio in Phillips 66 (NYSE:PSX).

Since May 16, 2018, it had 0 buys, and 1 insider sale for $828,000 activity. The insider Oyolu Chukwuemeka A. sold $828,000.

Phillips 66 (NYSE:PSX) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>